Search

Your search keyword '"Sisk, Robert A."' showing total 404 results

Search Constraints

Start Over You searched for: Author "Sisk, Robert A." Remove constraint Author: "Sisk, Robert A."
404 results on '"Sisk, Robert A."'

Search Results

3. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

7. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

9. Benign Yellow Dot Maculopathy A New Macular Phenotype

10. Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders

13. Ultrawidefield Fluorescein Angiography and OCT Findings in Children and Young Adults with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy

14. Neuropathy target esterase impairments cause Oliver–McFarlane and Laurence–Moon syndromes

15. TENAYA and LUCERNE

17. Human Cone Visual Pigment Deletions Spare Sufficient Photoreceptors to Warrant Gene Therapy

20. Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-rzyl for RPE65-mediated retinal degeneration

21. A SLEEPER WAKES: THE COOK CREEK RIDGE FIRE.

25. Neuropathy target esterase activity predicts retinopathy amongPNPLA6disorders

26. Immediate Sequential Bilateral Pediatric Vitreoretinal Surgery: An International Multicenter Study

27. Neuropathy target esterase activity predicts retinopathy among PNPLA6 disorders

28. Reply

32. Comparative Effectiveness of the Dexamethasone Intravitreal Implant in Vitrectomized and Non-vitrectomized Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion

36. INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA–RELATED CYSTOID MACULAR EDEMA

45. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

46. Dual phenotype: co-occurring Leber congenital amaurosis and familial exudative vitreoretinopathy: a case report.

50. Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases

Catalog

Books, media, physical & digital resources